CAR T-cell therapy for solid tumours may advance cancer treatments
Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising…
Browsing: solid tumours
ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective
Treatment with dabrafenib and trametinib, a drug combination designed to target cancers that harbour certain…